Bile salt tolerance enhancement and survival mechanism in Limosilactobacillus fermentum M2 mediated by Kluyveromyces marxianus Y4.

Authors

Pengcheng Li, Ziqi Liu, Shengxue Ye, Tingyu Zhang, Xiujuan Wang, Yuhua Wang, Chunhong Piao

Published in

Food research international (Ottawa, Ont.). Volume 242. Issue Pt 5. Pages 120151. Oct 31, 2026. Epub Jul 29, 2026.

Abstract

Enhancing the survival capacity of probiotic strains under bile salt (BS) stress via probiotic interactions constitutes a highly prospective novel strategy within the domain of probiotic applications. In this study, based on probiotic characterization of two probiotic strains, designated Limosilactobacillus fermentum M2 and Kluyveromyces marxianus Y4, the viable counts of L. fermentum M2 under BS stress reached from 9.1 to 7.34 log CFU/mL, while co-culture with K. marxianus Y4 significantly increased the survival of L.fermentum M2 by 76.4% compared with monoculture (p < 0.05). In contrast, no significant difference was observed under non - BS stress conditions. Meanwhile metabolites of BS treatment K. marxianus Y4 (BSTKM) enhanced the survival ability of L.fermentum M2 exposed to BS. The observations of the microbial microstructure confirm that BSTKM exerts a protective effect by preserving the structural integrity of L.fermentum M2. Subsequently, metabolomic analysis was performed to identify differential metabolites between BSTKM and BS, while proteomic profiling was used to investigate the differential protein expression in L.fermentum M2 under BSTKM and BS stress. Integrated multi - omics analysis suggested that differential metabolites such as biotin, amino acids, and purines may be associated with DNA repair processes, thereby enhancing the survival ability of L.fermentum M2 under BS stress. This study provides a theoretical foundation for improving the survivability of lactic acid bacteria (LAB) under BS conditions and proposes new perspectives on LAB - yeast symbiotic interactions.

PMID:
42637327
Bibliographic data and abstract were imported from PubMed on 25 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.